SLE patients with active symptoms are found to have a higher proportion of Th17 cells and serum IL-17 levels compared to the healthy controls, and Th17 lymphocyte numbers are positively correlated with SLE disease activity and severity (53)
[8] Metformin with GLP-RA & Long-term Outcomes: In patients with T2D, dual therapy with metformin and GLP-RA has demonstrated a 39% lower incidence of adiposity-related cancers (HR 0.61) and a 67% reduction in all-cause mortality (HR 0.33) compared to DPP-4 inhibitor use, with effects most pronounced in younger people with obesity
PlexusDx compounded semaglutide works through the same GLP-1 receptor mechanism as Ozempic, offering identical pharmacological benefits without the brand-name markup
Contact your GP or diabetes specialist before taking your next dose if you are unsure about timing, experiencing ongoing postoperative symptoms, or if your surgical team has not provided clear guidance
This decline in weight was partially attenuated by treatment with GLP-1-SSM in DSS + GLP-1-SSM group (loss of 2.05 0.36)
Weight gain despite treatment warrants a review of the regimen and additional support or intervention
